drugset / Trial / NCT00703183
Safety and Tolerability of ACU-4429
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of a new investigational drug (ACU-4429) in healthy human volunteers.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Emixustat | Small molecule | — | Oral |
Indications
No indication recorded.